Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 2, 2010, Pages 357-361

  Oliveira, Claudia Pinto Marques Souza ^a   Stefano, José Tadeu ^a   Cavaleiro, Ana Mercedes ^a   Zanella Fortes, Maria Angela Henriques ^a   Vieira, Suzana Maria ^a   Rodrigues Lima, Vicência Mara ^a   Santos, Telma Eugenio ^a   Santos, Virginia Nascimento ^b   De Azevedo Salgado, Ana Lucia Farias ^b   Parise, Édson Roberto ^b   Ferreira Alves, Venâncio Avancini ^a   Carrilho, Flair José ^a   Corrêa Giannella, Maria Lucia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Fatty liver; Genetic polymorphisms; Genetic susceptibility; Glutamate cystein ligase; Glutathione; Lipid metabolism; Microsomal TG transfer protein; Oxidative stress

Indexed keywords

APOLIPOPROTEIN B; GENOMIC DNA; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; MALE; NONALCOHOLIC FATTY LIVER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 76149095904     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06001.x     Document Type: Article

References (23)

1. Adams LA, Sanderson S, Lindor K, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J. Hepatol. 2005 42 : 132 138.
2. Ekstedt M, Franzén LE, Mathiesen UL et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006 44 : 865 873.
3. Bugianesi E. Non-alcoholic Steatohepatitis and Cancer. Clin. Liver Dis. 2007 11 : 191 207.
4. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006 6 : 1 38.
5. Oliveira CPMS, Faintuch J, Rascovski A et al. Lipid peroxidation in nonalcoholic fatty liver disease (NAFLD) in morbid obese patients. Obes. Surg. 2005 15 : 502 505.
6. Hensley K. Dietary choline restriction causes complex I dysfunction and increased H2O2 generation in liver mitochondria. Carcinogenesis 2000 21 : 983 989.
7. Oliveira CP, Gayotto LCC, Tatai C et al. Oxidative stress in pathogenesis of experimental liver steatosis in rats fed choline deficient diet. J. Cell. Mol. Med. 2002 6 : 399 406.
8. Marra F, Gastaldelli A, Baroni GS, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol. Med. 2008 14 : 72 81.
9. Yesilova Z, Yaman H, Oktenli C et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease. Am. J. Gastroenterol. 2005 100 : 850 855.
10. Namikawa C, Shu-Ping Z, Vyselaar JR et al. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J. Hepatol. 2004 40 : 781 786.
11. Wetterau JR, Lin MC, Jamil H. Microsomal triglyceride transfer protein. Biochim. Biophys. Acta 1997 1345 : 136 150.
12. Partin JS, Partin JC, Schubert WK, McAdams AJ. Liver ultrastructure in abetalipoproteinemia: evolution of micronodular cirrhosis. Gastroenterology 1974 67 : 107 118.
13. Perlemuter G, Sabile A, Letteron P et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEBJ 2002 16 : 185 194.
14. Karpe F, Lundahl B, Ehrenborg E, Eriksson P, Hamsten A. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscl. Throm. Vas. 1998 18 : 756 761.
15. Bernard S, Touzet S, Personne I et al. Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes. Diabetologia 2000 43 : 995 999.
16. Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr. Opin. Lipidol. 2005 16 : 421 427. (Pubitemid 41017626)
17. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histologic scoring system for NAFLD. Hepatology 2005 41 : 1313 1321.
18. Koide S. Association of Polymorphism in Glutamate-Cysteine Ligase Catalytic Subunit Gene with Coronary vasomotor dysfunction and myocardial infarction. J. Am. Coll. Cardiol. 2003 41 : 539 545.
19. Pessayre D, Mansouri A, Fromenty B. Nonalcoholic steatosis and steatohepatitis. Mitochondrial dysfunction in steatohepatitis. Am. J. Physiol.-Gastr. L. 2002 282 : 193 199.
20. Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C et al. GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am. J. Physiol. 1997 273 : 7 17.
21. Garcia-Ruiz C, Fernandez-Checa JC. Mitochondrial glutathione: hepatocellular survival-death switch. J. Gastroenterol. Hepatol. 2006 21 : S3 S6.
22. Sanyal AJ, Campbell Sargent C, Mirshahi F et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001 120 : 1183 1192.
23. Alwis NMW, Day CP. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin. Liver Dis. 2007 27 : 44 54.